P-295 Consequences of embryos transfer following fresh biopsy (single vitrification) and frozen-thaw embryo biopsy (double vitrification) after preimplantation genetic testing for aneuploidy: A retrospective cohort analysis

IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY
D D Dave, P Joshi, V Bansi, V Sisodiya, D Talwar, R Aggarwal, N Shah, V Chandra, N Murdia, K Murdia, W Mistari
{"title":"P-295 Consequences of embryos transfer following fresh biopsy (single vitrification) and frozen-thaw embryo biopsy (double vitrification) after preimplantation genetic testing for aneuploidy: A retrospective cohort analysis","authors":"D D Dave, P Joshi, V Bansi, V Sisodiya, D Talwar, R Aggarwal, N Shah, V Chandra, N Murdia, K Murdia, W Mistari","doi":"10.1093/humrep/deaf097.603","DOIUrl":null,"url":null,"abstract":"Study question Does exposure of embryos to double vitrification and double warming affect the chances of ongoing pregnancy for patients undergoing embryo biopsy and euploid embryos transfer? Summary answer A significantly higher statistical clinical outcomes were established in fresh embryo biopsy as compared to freeze-thaw embryo biopsy cycles. What is known already In couples and clinicians, often uncertainty is observed while testing cryopreserved embryos for embryo selection via preimplantation genetic testing for aneuploidy (PGT-A). The utilization of PGT-A over the years has been augmented and leads to the lowering down of the genetic disorders in neonates. The effect of transferring euploid thaw, biopsy, refreeze (TBR) embryos is inconclusive and ESHRE PGT Consortium and SIG Embryology good practice recommendations of 2020 depicted that multiple cryopreservation and its impact on pregnancy outcomes requires further investigations. This investigation aims to uncover the effects of transferring a freeze-thaw biopsy embryos in comparison to fresh biopsy embryos. Study design, size, duration It is a single centric retrospective observational study conducted during the timeline of May 2021 to September 2024 with data of 181 frozen euploid embryo transfers (FETs). The research had two arms, embryos underwent fresh PGT-A, control group (n = 114) and embryos underwent freeze-thaw PGT-A, comparative group (n = 67). The research included a maximum of two grade 1 embryo transfers and the bias was eliminated by matching the patient’s characteristics and indications and embryo morphology. Participants/materials, setting, methods In fresh PGT-A group, the embryos were cultured till day5 or 6 using standard protocol and PGT-A was performed by aspirating 5-10 cells from trophectoderm and vitrified until transfer. In the freeze-thaw PGT-A group (previous failure) the good embryos vitrified on day5 or 6 were thawed for PGT-A and re-vitrified until transfer. The clinical outcomes in the groups were estimated. Statistical analysis was performed using chi-square and Fisher Exact test and p < 0.05 was considered significant. Main results and the role of chance Our investigation decodes that in the freeze-thaw embryo biopsy (n = 67) a reduction in clinical pregnancy rate (CPR) of 17.5% was observed compared to fresh embryo biopsy (n = 114) (59.7%, 77.2%; p = 0.018). CPR is defined as the presence of a vital fetal heart observed at 6-8 weeks scan. For biochemical pregnancy rate (BPR) a decrease of 15.9% was seen in the freeze-thaw embryo biopsy group compared with the control group (65.7%, 81.6%; p = 0.020). The pregnancy of the patients was tracked till 12 weeks (ongoing pregnancy rate) and a decline of 15.2% was observed in freeze-thaw embryo biopsy group compared with the control group (56.7%, 71.9%; p = 0.048). Simultaneously, the trimester losses were also calculated, and it was observed that biochemical loss rate was higher by 3.7% in patients underwent freeze-thaw embryo biopsy as compared to controls. However, the first trimester loss was higher in control group by 1.8% compared to freeze-thaw embryo biopsy group. The difference in biochemical loss and first trimester loss failed to attain significance. Limitations, reasons for caution This is a retrospective observational study. To elucidate the underlying insights of impact on pregnancy outcomes after euploid TBR transfer, a prospective comparative analysis is required. Wider implications of the findings The investigation depicts that if the embryo diagnose via PGT-A has to be performed, then patients must be counselled, and PGT-A must be conducted on fresh embryos. The multiple vitrification maybe necessary in amplification failures but could have an adverse impact on reproductive outcomes even for good quality blastocysts. Trial registration number No","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":"46 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human reproduction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/humrep/deaf097.603","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Study question Does exposure of embryos to double vitrification and double warming affect the chances of ongoing pregnancy for patients undergoing embryo biopsy and euploid embryos transfer? Summary answer A significantly higher statistical clinical outcomes were established in fresh embryo biopsy as compared to freeze-thaw embryo biopsy cycles. What is known already In couples and clinicians, often uncertainty is observed while testing cryopreserved embryos for embryo selection via preimplantation genetic testing for aneuploidy (PGT-A). The utilization of PGT-A over the years has been augmented and leads to the lowering down of the genetic disorders in neonates. The effect of transferring euploid thaw, biopsy, refreeze (TBR) embryos is inconclusive and ESHRE PGT Consortium and SIG Embryology good practice recommendations of 2020 depicted that multiple cryopreservation and its impact on pregnancy outcomes requires further investigations. This investigation aims to uncover the effects of transferring a freeze-thaw biopsy embryos in comparison to fresh biopsy embryos. Study design, size, duration It is a single centric retrospective observational study conducted during the timeline of May 2021 to September 2024 with data of 181 frozen euploid embryo transfers (FETs). The research had two arms, embryos underwent fresh PGT-A, control group (n = 114) and embryos underwent freeze-thaw PGT-A, comparative group (n = 67). The research included a maximum of two grade 1 embryo transfers and the bias was eliminated by matching the patient’s characteristics and indications and embryo morphology. Participants/materials, setting, methods In fresh PGT-A group, the embryos were cultured till day5 or 6 using standard protocol and PGT-A was performed by aspirating 5-10 cells from trophectoderm and vitrified until transfer. In the freeze-thaw PGT-A group (previous failure) the good embryos vitrified on day5 or 6 were thawed for PGT-A and re-vitrified until transfer. The clinical outcomes in the groups were estimated. Statistical analysis was performed using chi-square and Fisher Exact test and p < 0.05 was considered significant. Main results and the role of chance Our investigation decodes that in the freeze-thaw embryo biopsy (n = 67) a reduction in clinical pregnancy rate (CPR) of 17.5% was observed compared to fresh embryo biopsy (n = 114) (59.7%, 77.2%; p = 0.018). CPR is defined as the presence of a vital fetal heart observed at 6-8 weeks scan. For biochemical pregnancy rate (BPR) a decrease of 15.9% was seen in the freeze-thaw embryo biopsy group compared with the control group (65.7%, 81.6%; p = 0.020). The pregnancy of the patients was tracked till 12 weeks (ongoing pregnancy rate) and a decline of 15.2% was observed in freeze-thaw embryo biopsy group compared with the control group (56.7%, 71.9%; p = 0.048). Simultaneously, the trimester losses were also calculated, and it was observed that biochemical loss rate was higher by 3.7% in patients underwent freeze-thaw embryo biopsy as compared to controls. However, the first trimester loss was higher in control group by 1.8% compared to freeze-thaw embryo biopsy group. The difference in biochemical loss and first trimester loss failed to attain significance. Limitations, reasons for caution This is a retrospective observational study. To elucidate the underlying insights of impact on pregnancy outcomes after euploid TBR transfer, a prospective comparative analysis is required. Wider implications of the findings The investigation depicts that if the embryo diagnose via PGT-A has to be performed, then patients must be counselled, and PGT-A must be conducted on fresh embryos. The multiple vitrification maybe necessary in amplification failures but could have an adverse impact on reproductive outcomes even for good quality blastocysts. Trial registration number No
P-295胚胎移植前非整倍体基因检测后新鲜活检(单玻璃化)和冷冻解冻胚胎活检(双玻璃化)的后果:回顾性队列分析
胚胎暴露于双重玻璃化和双重加热是否会影响接受胚胎活检和整倍体胚胎移植的患者继续妊娠的机会?与冻融胚胎活检周期相比,新鲜胚胎活检的统计临床结果明显更高。在夫妇和临床医生中,通过植入前基因检测非整倍体(PGT-A)对冷冻保存的胚胎进行胚胎选择时,经常观察到不确定性。多年来,PGT-A的利用得到了加强,并导致新生儿遗传疾病的降低。移植整倍体解冻、活检、再冷冻(TBR)胚胎的效果尚不确定,ESHRE PGT联合会和SIG胚胎学2020年良好实践建议表明,多次冷冻保存及其对妊娠结局的影响需要进一步研究。本研究旨在揭示冻融活检胚胎移植与新鲜活检胚胎移植的效果。这是一项单中心回顾性观察性研究,研究时间为2021年5月至2024年9月,数据为181例冷冻整倍体胚胎移植(fet)。研究分为两组,对照组(n = 114)胚胎采用新鲜PGT-A,对照组(n = 67)胚胎采用冻融PGT-A。该研究包括最多两次1级胚胎移植,并通过匹配患者的特征和适应症以及胚胎形态来消除偏差。新鲜PGT-A组,胚胎按照标准方案培养至第5天或第6天,从滋养外胚层抽吸5-10个细胞进行PGT-A,玻璃化直至移植。在冻融PGT-A组(先前失败)中,在第5天或第6天玻璃化的良好胚胎解冻用于PGT-A并重新玻璃化直至移植。评估各组临床结果。统计学分析采用卡方检验、Fisher精确检验和p &;lt;0.05被认为是显著的。我们的研究表明,冻融胚胎活检(n = 67)的临床妊娠率(CPR)比新鲜胚胎活检(n = 114) (59.7%, 77.2%;P = 0.018)。心肺复苏术的定义是在6-8周的扫描中观察到一个重要的胎儿心脏。冻融胚胎活检组生化妊娠率(BPR)较对照组下降15.9% (65.7%,81.6%;P = 0.020)。随访患者妊娠至12周(持续妊娠率),冻融胚胎活检组与对照组相比下降15.2% (56.7%,71.9%;P = 0.048)。同时,我们还计算了妊娠期损失,结果发现冷冻解冻胚胎活检组的生化损失率比对照组高3.7%。然而,与冻融胚胎活检组相比,对照组的妊娠早期损失高1.8%。生化损失和妊娠早期损失的差异没有达到显著性。这是一项回顾性观察性研究。为了阐明整倍体TBR移植后对妊娠结局影响的潜在见解,需要进行前瞻性比较分析。调查表明,如果必须通过PGT-A进行胚胎诊断,那么必须向患者提供咨询,并且必须在新鲜胚胎上进行PGT-A。在扩增失败的情况下,多次玻璃化可能是必要的,但即使对于质量好的囊胚,也可能对生殖结果产生不利影响。试验注册号
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human reproduction
Human reproduction 医学-妇产科学
CiteScore
10.90
自引率
6.60%
发文量
1369
审稿时长
1 months
期刊介绍: Human Reproduction features full-length, peer-reviewed papers reporting original research, concise clinical case reports, as well as opinions and debates on topical issues. Papers published cover the clinical science and medical aspects of reproductive physiology, pathology and endocrinology; including andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, early pregnancy, genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信